4D Molecular Therapeutics, Inc. (FDMT)
11.37
+0.45
(+4.12%)
USD |
NASDAQ |
Dec 12, 10:14
4D Molecular Therapeutics EPS Diluted (Quarterly): -1.013 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Aura Biosciences, Inc. | -0.3963 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.88M |
| Revenue (Quarterly) | 0.09M |
| Total Expenses (Quarterly) | 56.97M |
| Enterprise Value | 341.12M |
| Gross Profit Margin (Quarterly) | -2.13K% |
| Profit Margin (Quarterly) | -63.20K% |
| Earnings Yield | -34.62% |
| Normalized Earnings Yield | -34.62 |